Neeta Somaiah, MD

Dr. Somaiah joined MD Anderson Cancer Center in 2012 . She has thirteen years of
sarcoma and clinical research experience. She is board certified in Medical Oncology.
Her primary clinical and research focus is soft tissue sarcomas, specifically
liposarcomas and GIST. She currently serves as the Principal Investigator of three
investigator-initiated trials and nine cooperative group and industry-sponsored clinical
trials at MD Anderson Cancer Center and has in depth knowledge with extensive
experience in the design and execution of clinical trials. She also has multiple ongoing
collaborations for translational research, both retrospective and prospective, that help
improve the understanding of these rare group of diseases and explore the role of
immunotherapy as a therapeutic avenue. Dr. Somaiah has been presented many
honors for her expertise and contributions to science, including an Exceptional Women
in Medicine award and is among the top 1% providers nationally (CG-CAHPS Patient
Surveys).
Financial relationships
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:BayerDate added:06/02/2025Date updated:06/02/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:DecipheraDate added:06/02/2025Date updated:06/02/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:IDRXDate added:06/02/2025Date updated:06/02/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:CogentDate added:06/02/2025Date updated:06/02/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Boehringer IngelheimDate added:06/02/2025Date updated:06/02/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:AscentageDate added:06/02/2025Date updated:06/02/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:AstrazenecaDate added:06/02/2025Date updated:06/02/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:DecipheraDate added:06/02/2025Date updated:06/02/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:IpsenDate added:06/02/2025Date updated:06/02/2025